Literature DB >> 9015403

Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs.

M Van de Velde1, P F Wouters, N Rolf, H Van Aken, W Flameng, E Vandermeersch.   

Abstract

OBJECTIVES: Free fatty acid (FFA) oxidation is depressed in the postischaemic stunned myocardium and recovers in parallel with the normalization of contractile performance. Assuming a causal role for this metabolic disturbance in the pathogenesis of stunning, we questioned whether exogenous administration of high dose triglycerides during reperfusion of postischaemic myocardium, could improve its functional recovery.
METHODS: Thirteen dogs were chronically instrumented to measure global and regional haemodynamics and to produce a 10 min episode of regional myocardial ischaemia. In 7 dogs, Intralipid 20% was administered i.v. during the reperfusion phase. Contractile recovery of stunned myocardium was compared with control saline treatments. The series were repeated in another 6 animals, but oxfenicine (CPT I inhibitor) preceeded Intralipid during reperfusion.
RESULTS: Contractile recovery of stunned myocardium was faster and more extensive when Intralipid was administered during reperfusion than with saline treatment (wall thickening fraction 86 +/- 6% of preischaemic controls versus 52 +/- 11% at 90 min post-reperfusion; P < 0.05). Oxfenicine pretreatment completely abolished this beneficial effect.
CONCLUSIONS: Exogenous administration of triglycerides during reperfusion of postischaemic myocardium improves functional recovery from stunning. This beneficial effect most likely operates through enhanced FFA availability and/or oxidation since it could be abolished by selective inhibition of the carnitine palmitoyl I enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9015403     DOI: 10.1016/s0008-6363(96)00165-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  Lipid emulsion rapidly restores contractility in stunned mouse cardiomyocytes: a comparison with therapeutic hypothermia.

Authors:  Jing Li; Michael Fettiplace; Sy-Jou Chen; Benjamin Steinhorn; Zuohui Shao; Xiangdong Zhu; Changqing Li; Shaun Harty; Guy Weinberg; Terry L Vanden Hoek
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

2.  Review of management in cardiotoxic overdose and efficacy of delayed intralipid use.

Authors:  Edward Walter; James McKinlay; Jade Corbett; Justin Kirk-Bayley
Journal:  J Intensive Care Soc       Date:  2017-06-13

3.  Intravenous lipid emulsion alters the hemodynamic response to epinephrine in a rat model.

Authors:  Stephanie Carreiro; Jared Blum; Gregory Jay; Jason B Hack
Journal:  J Med Toxicol       Date:  2013-09

Review 4.  Intravenous lipid emulsion in clinical toxicology.

Authors:  Leelach Rothschild; Sarah Bern; Sarah Oswald; Guy Weinberg
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-10-05       Impact factor: 2.953

5.  The role of fat emulsion therapy in a rodent model of propranolol toxicity: a preliminary study.

Authors:  Grant Cave; Martyn G Harvey; Craig D Castle
Journal:  J Med Toxicol       Date:  2006-03

6.  Intralipid infusion ameliorates propranolol-induced hypotension in rabbits.

Authors:  Martyn G Harvey; Grant R Cave
Journal:  J Med Toxicol       Date:  2008-06

7.  Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect.

Authors:  Michael R Fettiplace; Belinda S Akpa; Richard Ripper; Brian Zider; Jason Lang; Israel Rubinstein; Guy Weinberg
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

8.  ω-3 Polyunsaturated Fatty Acid Postconditioning Protects the Isolated Perfused Rat Heart from Ischemia-Reperfusion Injury.

Authors:  Fu-Wei Zhang; Jian Tong; Yu-Sheng Yan; Qun-Qing Chen; Xiao-Ping Zhao
Journal:  Cardiorenal Med       Date:  2018-04-11       Impact factor: 2.041

Review 9.  Glucose-insulin therapy, plasma substrate levels and cardiac recovery after cardiac ischemic events.

Authors:  C J Zuurbier; H B Van Wezel
Journal:  Cardiovasc Drugs Ther       Date:  2008-04       Impact factor: 3.727

10.  The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.

Authors:  Phing-How Lou; Eliana Lucchinetti; Liyan Zhang; Andreas Affolter; Marcus C Schaub; Manoj Gandhi; Martin Hersberger; Blair E Warren; Hélène Lemieux; Hany F Sobhi; Alexander S Clanachan; Michael Zaugg
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.